机构

• 上海药物研究所 [5]
• 合肥物质科学研究院 [3]

采集方式

• OAI收割 [8]

内容类型

• 期刊论文 [8]

发表日期

• 2019 [1]
• 2018 [1]
• 2016 [1]
• 2009 [1]
• 2007 [2]
• 2006 [2]
• 更多

学科主题

• Oncology [2]
• Biochemist... [1]
• Biophysics [1]

筛选

浏览/检索结果: 共8条，第1-8条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择题名升序题名降序提交时间升序提交时间降序作者升序作者降序发表日期升序发表日期降序 Discovery and characterization of a novel highly potent and selective type II native and drug-resistant V299L mutant BCR-ABL inhibitor (CHMFL-ABL-039) for Chronic Myeloid Leukemia (CML) 期刊论文  OAI收割 CANCER BIOLOGY & THERAPY, 2019, 卷号: 20, 期号: 6, 页码: 877-885 作者:  Wu, Jiaxin;  Wang, Aoli;  Li, Xixiang;  Chen, Cheng;  Qi, Ziping   |  收藏  |  浏览/下载：88/0  |  提交时间：2019/11/27 BCR-ABL  PDGFR  chronic myeloid leukemia  kinase inhibitor   Discovery of 4-((N-(2-(dimethylamino)ethyl)acrylamido)methyl)-N-(4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)benzamide (CHMFL-PDGFR-159) as a highly selective type II PDGFR alpha kinase inhibitor for PDGFR alpha driving chronic eosinophilic leukemia 期刊论文  OAI收割 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 卷号: 150, 期号: 无, 页码: 366-384 作者:  Wang, Qiang;  Liu, Feiyang;  Qi, Shuang;  Qi, Ziping;  Yan, Xiao-E.   |  收藏  |  浏览/下载：76/0  |  提交时间：2019/06/10 PDGFR kinase  Type II inhibitor  Kinase inhibitor  CEL   Discovery and characterization of a novel potent type II native and mutant BCR-ABL inhibitor (CHMFL-074) for Chronic Myeloid Leukemia (CML) 期刊论文  OAI收割 ONCOTARGET, 2016, 卷号: 7, 期号: 29, 页码: 45562-45574 作者:  Liu, Feiyang;  Wang, Beilei;  Wang, Qiang;  Qi, Ziping;  Chen, Cheng 收藏  |  浏览/下载：49/0  |  提交时间：2017/11/21 Bcr-abl  Pdgfr  Chronic Myeloid Leukemia  Kinase Inhibitor   Establishment of the active catalytic domain of human PDGFR beta tyrosine kinase-based ELISA assay for inhibitor screening 期刊论文  OAI收割 BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2007, 卷号: 1770, 期号: 10, 页码: 1490-1497 作者:  Zhang, Xiu-Hua;  Guo, Xiao-Ning;  Zhong, Li;  Luo, Xiao-Min;  Jiang, Hua-Liang   |  收藏  |  浏览/下载：25/0  |  提交时间：2019/01/08 PDGFR beta  bac-to-bac system  tyrosine kinase inhibitors  TKI-30   TKI-31 inhibits angiogenesis by combined suppression signaling pathway of VEGFR2 and PDGFR beta 期刊论文  OAI收割 CANCER BIOLOGY & THERAPY, 2006, 卷号: 5, 期号: 3, 页码: 323-330 作者:  Zhong, L;  Guo, XN;  Zhang, XH;  Sun, QM;  Tong, LJ   |  收藏  |  浏览/下载：26/0  |  提交时间：2019/01/08 tyrosine kinase  VEGFR2  PDGFR beta  angiogenesis